[Ibogaine] Bush approves unlimited prescribing of Suboxone?

Preston Peet ptpeet at nyc.rr.com
Sun Aug 14 21:22:26 EDT 2005


oh, thanks Howard, but the brochure that came with the advert for 
bup/nalwhatever it is says, for a whole page, don't take with liver problems 
or damaged liver whatsoever. It's not the opiate in the bup I'm worried 
about, it's the stuff that makes one sick IF trying to boot the stuff, as 
well as other weird things I keep hearing about the stuff, about how sick 
folk stay while on it, etc.


Peace and love,
Preston

"Madness is not enlightenment, but the search for enlightenment is often 
mistaken for madness"
Richard Davenport-Hines

ptpeet at nyc.rr.com
Editor http://www.drugwar.com
Editor "Under the Influence- the Disinformation Guide to Drugs"
Editor "Underground- The Disinformation Guide to Ancient Civilizations, 
Astonishing Archeology and Hidden History" (due out Sept. 2005)
Cont. High Times mag/.com
Cont. Editor http://www.disinfo.com
Columnist New York Waste
Etc.

----- Original Message ----- 
From: HSLotsof at aol.com
To: ibogaine at mindvox.com
Sent: Sunday, August 14, 2005 8:09 PM
Subject: Re: [Ibogaine] Bush approves unlimited prescribing of Suboxone?



In a message dated 8/14/05 5:37:47 PM, ptpeet at nyc.rr.com writes:



When I could sit and tell one of the docs at my pain specialists' office 
that I used opiates partly due to Hep C and more importantly because they 
work very effectively for pain, and not wanting to use anything more toxic, 
like Bup, prefering not to risk such toxic stuff on my liver, he STILL told 
me "here's a brochure for Bup/Nal, and I think you should think about 
switching to it," I'm amazed that the propaganda against opiates is so great 
that even a doc who should know better didn't/doesn't. That stuff scares the 
heck outta me, as do those pushing it.



Buprenorphine is an opioid having both agonist and antagonist actions. The 
manufacturer is Reckitt Benckiser and its use in the treatment of opioid 
dependence disorders was the result of a collaborative research and 
development agreement (CRDA) between NIDA and Reckitt Benckiser.  A 
principal advantage of buprenorphine over methadone is that it can be 
dispensed by a doctor writing a prescription rather than having to be 
dispensed out of a designated clinic as is methadone for the treatment of 
chemical dependence.  Both drugs can be Rxd for pain. A key issue of NIDA 
not choosing to develop ibogaine was their concurrent CRDA for buprenorphine 
development.

You might want to take a look at www.ibogaine.org/nycibogaforum.ppt which is 
a powerpoint slide presentation titled, Patient Medication Acceptability and 
Treatment Options:
Ibogaine. Methadone. Buprenorphine.

If you don't have a PowerPoint reader you can get one free from 
http://www.microsoft.com/downloads/details.aspx?FamilyId=D1649C22-B51F-4910-93FC-4CF2832D3342&displaylang=en

Howard

Howard 




More information about the Ibogaine mailing list